144 related articles for article (PubMed ID: 37088659)
1. Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-only.
Richardson NH; Althouse SK; Ashkar R; Cary C; Masterson T; Foster RS; Einhorn LH; Adra N
Clin Genitourin Cancer; 2023 Aug; 21(4):467-474. PubMed ID: 37088659
[TBL] [Abstract][Full Text] [Related]
2. Late relapsing germ cell tumors with elevated tumor markers.
Che Y; Lusch A; Winter C; Große Siemer R; Buddensieck C; Albers P; Hiester A
World J Urol; 2022 Feb; 40(2):363-371. PubMed ID: 34518930
[TBL] [Abstract][Full Text] [Related]
3. Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery.
Alifrangis C; Lucas O; Benafif S; Ansell W; Greenwood M; Smith S; Wilson P; Thomas B; Rudman S; Mazhar D; Berney D; Shamash J
Eur Urol Focus; 2021 Jul; 7(4):835-842. PubMed ID: 32381397
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of late relapse on surveillance in patients presenting with clinical stage I testicular cancer.
Rice KR; Beck SD; Pedrosa JA; Masterson TA; Einhorn LH; Foster RS
Urology; 2014 Oct; 84(4):886-90. PubMed ID: 25260450
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
6. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
7. Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
Taza F; Abonour R; Zaid MA; Althouse SK; Anouti B; Akel R; Hanna NH; Adra N; Einhorn LH
Clin Genitourin Cancer; 2023 Apr; 21(2):213-220. PubMed ID: 36737276
[TBL] [Abstract][Full Text] [Related]
8. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.
Dieckmann KP; Albers P; Classen J; De Wit M; Pichlmeier U; Rick O; Müllerleile U; Kuczyk M
J Urol; 2005 Mar; 173(3):824-9. PubMed ID: 15711278
[TBL] [Abstract][Full Text] [Related]
9. Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older.
Feldman DR; Voss MH; Jacobsen EP; Jia X; Suarez JA; Turkula S; Sheinfeld J; Bosl GJ; Motzer RJ; Patil S
Cancer; 2013 Jul; 119(14):2574-81. PubMed ID: 23606402
[TBL] [Abstract][Full Text] [Related]
10. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
[TBL] [Abstract][Full Text] [Related]
11. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of testicular germ cell tumors relapse].
Carbonnaux M; Vinceneux A; Peyrat P; Fléchon A
Bull Cancer; 2020 Sep; 107(9):912-924. PubMed ID: 32653158
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515).
Bastos DA; Gongora ABL; Dzik C; Jardim DL; Piva M; Carcano FM; Bertollo G; Trindade K; Fontes MS; Soares A; Reinert T; De Cassia Costamilan R; Villarroel RU; Watarai G; Gazola AA; Preto DDA; Mutti H; Bonalumi Dos Santos M; Mariano RC; Binotto M; Carvalho MM; Oliveira VPDC; Gomes R; Rebelatto TF; Schutz FA; Smaletz O; Fay AP
Clin Genitourin Cancer; 2023 Jun; 21(3):e104-e113. PubMed ID: 36509612
[TBL] [Abstract][Full Text] [Related]
14. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
[TBL] [Abstract][Full Text] [Related]
15. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY
Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340
[TBL] [Abstract][Full Text] [Related]
16. Late relapse of germ cell tumors.
Oldenburg J; Wahlqvist R; Fosså SD
World J Urol; 2009 Aug; 27(4):493-500. PubMed ID: 19373473
[TBL] [Abstract][Full Text] [Related]
17. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
18. [Retroperitoneal residual tumor resection after chemotherapy of malignant testicular cancers].
Albers P
Aktuelle Urol; 2012 May; 43(3):197-206. PubMed ID: 22639031
[No Abstract] [Full Text] [Related]
19. Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options.
Francis R; Bower M; Brunström G; Holden L; Newlands ES; Rustin GJ; Seckl MJ
Eur J Cancer; 2000 Oct; 36(15):1925-32. PubMed ID: 11000572
[TBL] [Abstract][Full Text] [Related]
20. Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour.
Jay APM; Aldiwani M; O'Callaghan ME; Pearce AK; Huddart RA; Mayer E; Reid AH; Nicol DL
Eur Urol Open Sci; 2021 Jul; 29():82-88. PubMed ID: 34337537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
